Honey guide
Manuka Honey: Science vs Marketing
Manuka honey's antibacterial properties are real — methylglyoxal and UMF ratings explained. But many health claims go far beyond the evidence. UK buyers' guide.
By Honey Honey Honey · Published 3 June 2026
What makes Manuka honey different from other honeys?
Manuka honey comes from bees foraging on Leptospermum scoparium, a shrub native to New Zealand and parts of Australia. Its antibacterial activity is higher and more stable than most other honeys because it contains methylglyoxal (MGO) at concentrations far above those in any other honey type.
All honeys have some antibacterial properties: hydrogen peroxide from glucose oxidase, low water activity, acidic pH, and osmotic pressure. These mechanisms are effective but can be neutralised — hydrogen peroxide is broken down by catalase, and dilution with water reduces osmotic effects. When researchers added catalase to honey samples to block the hydrogen peroxide mechanism, most honeys lost most of their antibacterial activity. Manuka retained strong activity. This "non-peroxide activity" is the defining property that separates Manuka from other honeys.
The non-peroxide activity comes primarily from methylglyoxal. MGO reacts with proteins in bacterial cells — particularly with amino groups in DNA and proteins — disrupting bacterial function in ways that bacteria find difficult to develop resistance against. Unlike a single-target antibiotic, MGO acts on multiple sites, which is part of why interest in it as a complement to conventional wound treatment is growing.
Manuka honey also contains hydrogen peroxide activity (from glucose oxidase, like other honeys) and additional compounds including leptosperin, DHA (dihydroxyacetone, the MGO precursor), and various phenolics. High-quality Manuka has multiple overlapping antibacterial systems. This combination is genuinely distinct from British raw honeys.
That said, the degree to which this distinction matters depends entirely on the application. For clinical wound care, the difference is meaningful. For eating on toast, the practical difference is negligible.
What is methylglyoxal and where does it come from in Manuka?
Methylglyoxal is a reactive carbonyl compound — a small organic molecule with the formula C3H4O2. It is toxic to bacteria at sufficient concentrations because it reacts with amino acids, proteins, and DNA, disrupting cellular structures. The concentrations in high-grade Manuka honey are sufficient to have meaningful antibacterial effects in wound care applications.
MGO does not come directly from the Manuka plant's nectar. Instead, Manuka nectar contains unusually high concentrations of dihydroxyacetone (DHA). After bees collect the nectar and process it into honey, DHA converts to MGO through a non-enzymatic chemical reaction during storage. This conversion is slow — Manuka honey increases in MGO content over months and years as DHA converts. Fresh Manuka honey has lower MGO than well-aged Manuka honey.
The DHA content of Manuka nectar is much higher than in other plant nectars — this is what makes Manuka unique. Even if bees process it the same way they process any nectar, the starting chemistry of the Manuka plant's nectar determines the MGO potential of the finished honey.
This has a practical implication for buyers: MGO-rated honey should be tested after maturation, not immediately after extraction, because the rating will be lower if tested too early. Reputable producers age their Manuka honey and test finished product rather than fresh-extracted honey.
For comparison, standard raw honey typically contains less than 10mg/kg of methylglyoxal. Manuka honey rated MGO 250+ contains at least 250mg/kg. MGO 850+ products contain over 850mg/kg. These are not trivial differences — the antibacterial mechanism is genuinely dose-dependent.
What does the UMF (Unique Manuka Factor) rating actually measure?
UMF measures the overall non-peroxide antibacterial activity of Manuka honey, expressed as an equivalence to a phenol (carbolic acid) solution. A UMF rating of 10+ means the honey's non-peroxide antibacterial activity is equivalent to a 10% solution of phenol. Higher ratings mean stronger activity.
The UMF Honey Association (UMFHA), a New Zealand industry body, manages the UMF certification system. To carry the UMF trademark, honey must be independently tested for four markers: MGO concentration, DHA concentration, leptosperin (a compound unique to Manuka nectar), and HMF (hydroxymethylfurfural, a heat-damage indicator). All four must meet minimum thresholds for each UMF grade.
This multi-marker approach is designed to prevent fraud. Methylglyoxal alone can be added artificially to boost MGO readings. Leptosperin cannot be synthesised economically and cannot be added fraudulently — it must come from actual Manuka nectar. The combination of markers makes the UMF certification more reliable than MGO-only labelling.
The MGO rating system, used by some producers independently of UMF, measures only methylglyoxal concentration. It is a valid measurement but does not include the authenticity checks that UMF provides. A product can have an accurate MGO rating without being certified by UMFHA.
There is no UK government certification system for Manuka honey specifically. The FSA defers to New Zealand export standards for authenticity. Trading Standards has taken action against products sold as Manuka honey that contain little or no genuine Manuka, but enforcement is reactive rather than systematic. Buyers who want assurance should look for UMF certification from a UMFHA-registered producer.
What do clinical trials actually show about Manuka honey's effectiveness?
Clinical evidence for Manuka honey is strongest in wound care and weakest in the many other areas it is marketed for.
For wound healing: a Cochrane review found moderate evidence that honey heals partial-thickness burns more quickly than conventional dressings, and some evidence of benefit for leg ulcers and surgical wounds. The trials largely used medical-grade Manuka products. The evidence is genuine but comes with caveats: many trials are small, poorly blinded (it is difficult to blind patients to whether they are receiving honey dressings), and funded by honey product manufacturers.
For H. pylori (the bacterium that causes stomach ulcers): lab studies show MGO inhibits H. pylori in vitro. Small human trials have not demonstrated that eating Manuka honey meaningfully reduces H. pylori colonisation. The gastric environment and bioavailability make it unlikely that therapeutic MGO concentrations reach the stomach lining from dietary honey intake.
For sore throats and upper respiratory symptoms: a 2021 BMJ systematic review found honey superior to usual care including antihistamines and decongestants. The trials included in this review were not limited to Manuka, and the benefit appears to be from honey generally rather than specifically from Manuka.
For MRSA: in vitro evidence is solid. Clinical evidence for treating MRSA infections is limited to case reports and small observational studies, not randomised controlled trials.
The honest summary is that Manuka honey's clinical evidence base, while the strongest of any honey type, is limited in scope. The wound care evidence is the most credible. Claims about gut health, immune function, and general wellness exceed what the trial data supports.
What health claims for Manuka are not supported by the evidence?
Several categories of claim made in Manuka honey marketing are not supported by clinical evidence.
"Boosts immunity" or "supports the immune system" — these phrases are ubiquitous in Manuka marketing. There is no clinical trial evidence that consuming Manuka honey measurably improves immune function in healthy adults. Lab studies show some anti-inflammatory effects of honey compounds in cell cultures, but this does not translate to proven clinical benefit.
"Heals the gut" or "supports gut microbiome" — some in vitro studies suggest honey has prebiotic properties, and others show MGO inhibits H. pylori. Neither translates reliably to clinical outcomes in human trials. The gut is a complex environment and honey's effects on the microbiome in living people are not well characterised.
"Anti-ageing" and "antioxidant" claims — honey contains antioxidants, and this can be stated factually. Claiming that consuming Manuka honey reduces ageing or has measurable antioxidant health outcomes in people is not supported by clinical evidence.
"Treats infections" — Manuka honey applied to wounds as a dressing has antimicrobial action. Eating Manuka honey does not treat systemic infections. These are completely different interventions, but marketing language often blurs the distinction.
Under UK FSA rules (Assimilated Regulation 1924/2006), disease treatment or prevention claims are prohibited on food products. "Heals wounds" would be an illegal claim on a food product label. Medical honey products are regulated as medical devices, not foods, which is why they can make therapeutic claims. Food-grade Manuka honey cannot make the same claims legally.
How is the Manuka honey market regulated in the UK?
The UK does not have a domestic regulatory standard specific to Manuka honey. Regulation comes from three overlapping sources: New Zealand export standards, UK food labelling law, and FSA health claims rules.
New Zealand, the primary source of genuine Manuka honey, introduced a mandatory Manuka honey standard in 2018, managed by the Ministry for Primary Industries (MPI). Honey exported from New Zealand as "Manuka" must pass a five-attribute test: four chemical attributes including MGO and leptosperin, and DNA analysis to confirm Leptospermum scoparium pollen. This standard applies at the point of export and is designed to protect the integrity of New Zealand Manuka globally.
UK food labelling law requires that honey sold under a specific name (such as "Manuka") must genuinely be what it claims to be. Trading Standards and the FSA can and do investigate products that fail authenticity tests. The National Food Crime Unit has flagged Manuka honey fraud as a known issue — given the significant price premium, there is financial incentive to adulterate or mislabel cheaper honeys.
The FSA's Nutrition and Health Claims rules apply to any health claims on UK-sold honey, whether Manuka or otherwise. Disease treatment claims are prohibited. Sellers can state compositional facts (such as MGO content) but cannot claim the product treats conditions.
For consumers, the practical gaps in regulation mean that the label "Manuka honey" on its own, without UMF or MPI certification, is not a guarantee of authenticity. Some products sold as Manuka in UK health food shops have been found in testing to contain minimal Manuka content.
How does Manuka compare to raw British honey for antibacterial activity?
Raw British honey has real antibacterial activity, primarily through hydrogen peroxide production, low water activity, acidity, and osmotic pressure. These mechanisms are present in raw honeys of all types. Darker British honeys — heather, buckwheat — also have significant polyphenol content that adds to antibacterial activity.
The measurable difference is that Manuka honey, particularly high-grade varieties, has substantially higher antibacterial activity in standardised laboratory assays. The methylglyoxal mechanism is additive to the mechanisms that British honey also has. When the hydrogen peroxide mechanism is neutralised (as in the catalase assay), Manuka retains activity and British honey largely does not.
In practical terms for wound care: high-grade Manuka (UMF 15+ or MGO 500+) in a medical-grade product has more sustained and stronger antibacterial activity in the wound environment than raw British honey. For clinical applications where that sustained activity matters — chronic wounds, difficult infections, post-surgical sites — the difference is relevant.
For dietary use, the comparison is different. Both raw Manuka and raw British honey will soothe a sore throat through the same physical mechanisms (coating, anti-inflammatory, osmotic effect on mucosa). A tablespoon of raw heather honey or buckwheat honey in hot water does essentially the same job for a sore throat as a tablespoon of Manuka honey, and costs a fraction of the price.
British raw honey from local UK beekeepers is also fresher, has a shorter supply chain, and retains pollen from identifiable UK flora. For people prioritising local sourcing and provenance over maximum MGO content, British raw honey is a rational choice.
Why does Manuka honey cost so much, and is the premium justified?
Manuka honey is expensive for several interconnected reasons. Leptospermum scoparium flowers for a short period — typically two to six weeks — in areas of New Zealand where beekeeping access is difficult. Hive management during Manuka season requires moving bees to remote locations. Extraction, testing, certification, and international shipping add significant costs. The UMFHA certification process requires independent laboratory analysis for each batch.
High-grade Manuka (UMF 20+ or MGO 800+) requires bees to have foraging access to dense Manuka flowering over that short window, producing honey that meets very high MGO thresholds. The proportion of production that reaches the top grades is limited. Supply genuinely is constrained relative to global demand.
Whether the premium is justified depends entirely on the use case. For medical wound care, high-grade Manuka in a licensed product is worth the cost because the methylglyoxal concentration delivers clinical outcomes that cheaper alternatives do not. The NHS makes this calculation — it prescribes medical-grade Manuka honey products because for certain wound types, the outcomes justify the price relative to alternatives.
For eating a teaspoon in the morning as a general wellness practice, the premium is not justified by evidence. The incremental antibacterial benefit of Manuka MGO over raw British honey in a dietary context is negligible, because the honey is digested and the MGO does not reach meaningful concentrations in tissues or the bloodstream.
A practical UK buyer position: pay for high-grade Manuka if you need it for wound care. For everything else — sore throats, cooking, daily use — good raw British honey does the job at 5-10% of the price.
What should UK buyers look for on a Manuka label to avoid low-quality products?
Genuine high-quality Manuka honey should carry clear labelling with independently verified credentials.
Look for the UMF trademark from a UMFHA-registered company, or independent MGO testing from an accredited laboratory. The UMF rating (10+, 15+, 20+, 25+) or an equivalent MGO value (250+, 500+, 829+, 1200+) should be clearly stated. If neither is present and the label just says "Manuka honey" with no quantitative rating, treat it with scepticism.
New Zealand origin is essential. The jar should state the country of origin as New Zealand (or Australia for some Australian Manuka honeys from Leptospermum species). Vague "natural" or "forest honey" claims without origin are a red flag.
Batch traceability is a positive sign. Reputable producers can trace honey back to specific hives and regions. Some include QR codes linking to lab test certificates. This level of transparency indicates the producer stands behind their MGO claims.
Price is a rough guide. Genuine UMF 20+ Manuka honey costs upward of £40-60 for 250g from reputable suppliers. Products claiming UMF 20+ at £12 for 500g have almost certainly not met the testing requirements. The cost of independent UMF testing alone is substantial, and this is reflected in the price of genuine product.
Check the HMF (hydroxymethylfurfural) value if disclosed. HMF below 40mg/kg indicates the honey has not been damaged by heat or long storage. Some producers voluntarily publish full lab panels including HMF, moisture, and MGO. A producer willing to publish these figures is more likely to have a genuine product.
Retailers to avoid: discount shops, unverified marketplaces, and any product with suspicious packaging discrepancies or no UK importer details. UK Manuka honey sold through reputable health food shops, specialist honey retailers, or direct from registered UMFHA members is considerably more reliable.
Frequently asked questions
- What makes Manuka honey special?
- Manuka honey contains methylglyoxal (MGO), a compound that provides antibacterial activity independent of hydrogen peroxide. This non-peroxide activity is measurably stronger in Manuka than in most other honeys.
- What does UMF 10+ mean on a Manuka label?
- UMF (Unique Manuka Factor) measures non-peroxide antibacterial activity against a phenol standard. UMF 10+ means the activity is equivalent to a 10% phenol solution. Higher numbers indicate stronger activity.
- Is Manuka honey worth the price?
- For wound care and specific clinical applications, high-grade Manuka's methylglyoxal content provides real advantages. For general dietary use or sore throats, the premium over good-quality raw British honey is hard to justify based on evidence.
- Can Manuka honey cure infections?
- No honey can cure infections in the medical sense. Manuka has proven antibacterial properties useful in wound care. It is not a treatment for systemic infections and should not replace antibiotics when they are needed.
- Is all Manuka honey from New Zealand?
- True Leptospermum scoparium Manuka is from New Zealand or Australia. A New Zealand government standard defines authentic Manuka honey by MGO content, pollen analysis, and other markers. Some products labelled Manuka do not meet this standard.
- Does Manuka honey help with gut health?
- There is limited clinical evidence for this claim. Some lab studies suggest MGO has activity against H. pylori, but the evidence for meaningful gut health benefits in people from eating Manuka honey is weak.
- How do I check if Manuka honey is genuine?
- Look for UMF or MGO certification from a recognised body, New Zealand origin, and a batch number. The UMF Honey Association maintains a register of certified products.
- What is the difference between MGO and UMF ratings?
- MGO measures the concentration of methylglyoxal in mg/kg. UMF measures the overall non-peroxide antibacterial activity against a phenol standard. Roughly, UMF 10+ corresponds to MGO 263+, UMF 20+ to MGO 829+.